Article
A Fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the…
medRxiv · 2021 · Gupta, P.; Thomas, S. E.; Cory-Wright, J.; Sebastián-Pérez, V.; Burgess, A.; Cattermole, E.; Meghir, C.; Abell, C.; Coyne, A. G.; Jacobs, W. R.; Blundell, T. L.; Tiwari, S.; Mendes, V.
Key facts
| Title | A Fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis. |
|---|---|
| First author | Gupta, P.; Thomas, S. E.; Cory-Wright, J.; Sebastián-Pérez, V.; Burgess, A.; Cattermole, E.; Meghir, C.; Abell, C.; Coyne, A. G.; Jacobs, W. R.; Blundell, T. L.; Tiwari, S.; Mendes, V. |
| Journal | medRxiv |
| Published | Mar 12, 2021 |
| DOI | 10.1101/2021.03.12.435067 |
| Devices mentioned | K010696, K952425, K952466, K973350, K990827 |
| Product codes mentioned | CFJ, JHN, JIX, JIS, JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1